Michael Johnston
- Impaired innate immunity to rhinovirus in severe asthmatic childrenBy Michael Edwards, Nicolas Regamey, Marjolaine Vareille, Elisabeth Kieninger, Atul Gupta, Cara Bossley, Andrew Bush and Sebastian JohnstonMichael Edwards1Respiratory Medicine, Imperial College London, London, United KingdomNicolas Regamey2Division of Paediatric Respiratory Medicine, University Children's Hospital, Bern, SwitzerlandMarjolaine Vareille2Division of Paediatric Respiratory Medicine, University Children's Hospital, Bern, SwitzerlandElisabeth Kieninger2Division of Paediatric Respiratory Medicine, University Children's Hospital, Bern, SwitzerlandAtul Gupta3Respiratory Paediatrics, Royal Brompton & Harefield NHS Foundation Trust, Imperial College London, London, United KingdomCara Bossley3Respiratory Paediatrics, Royal Brompton & Harefield NHS Foundation Trust, Imperial College London, London, United KingdomAndrew Bush3Respiratory Paediatrics, Royal Brompton & Harefield NHS Foundation Trust, Imperial College London, London, United KingdomSebastian Johnston1Respiratory Medicine, Imperial College London, London, United Kingdom
- An anti-human ICAM-1 antibody inhibits human rhinovirus infection in the mouse model of human major group rhinovirus infectionBy Stephanie Traub, Alan Carruthers, Rebecca Dunmore, Leila Gogsadze, Nathan W. Bartlett, Weidong Hao, Qing Zhu, Katie Bernard, Michael Dymond, Andrew Leishman, Alison Humbles, Ian K. Anderson, Roland Kolbeck, Matthew Sleeman, Ted Wells and Sebastian L. JohnstonStephanie Traub1Department of Respiratory Infection, Imperial College London, London, United KingdomAlan Carruthers2Respiratory, Inflammation & Autoimmunity, MedImmune LLC, Cambridge, United KingdomRebecca Dunmore2Respiratory, Inflammation & Autoimmunity, MedImmune LLC, Cambridge, United KingdomLeila Gogsadze1Department of Respiratory Infection, Imperial College London, London, United KingdomNathan W. Bartlett1Department of Respiratory Infection, Imperial College London, London, United KingdomWeidong Hao4Respiratory, Inflammation & Autoimmunity, MedImmune LLC, Gaithersburg, United StatesQing Zhu4Respiratory, Inflammation & Autoimmunity, MedImmune LLC, Gaithersburg, United StatesKatie Bernard4Respiratory, Inflammation & Autoimmunity, MedImmune LLC, Gaithersburg, United StatesMichael Dymond3Respiratory and Inflammation Research Area, AstraZeneca, Charnwood, United KingdomAndrew Leishman3Respiratory and Inflammation Research Area, AstraZeneca, Charnwood, United KingdomAlison Humbles4Respiratory, Inflammation & Autoimmunity, MedImmune LLC, Gaithersburg, United StatesIan K. Anderson2Respiratory, Inflammation & Autoimmunity, MedImmune LLC, Cambridge, United KingdomRoland Kolbeck4Respiratory, Inflammation & Autoimmunity, MedImmune LLC, Gaithersburg, United StatesMatthew Sleeman2Respiratory, Inflammation & Autoimmunity, MedImmune LLC, Cambridge, United KingdomTed Wells3Respiratory and Inflammation Research Area, AstraZeneca, Charnwood, United KingdomSebastian L. Johnston1Department of Respiratory Infection, Imperial College London, London, United Kingdom
- Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasisBy Rachel Johnston, Fiona Shaw, Robert Wilson, Michael Loebinger and Lizzie FludeRachel Johnston1Physiotherapy, Royal Brompton and Harefield NHS Foundation Trust, London, United KingdomFiona Shaw1Physiotherapy, Royal Brompton and Harefield NHS Foundation Trust, London, United KingdomRobert Wilson2Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United KingdomMichael Loebinger2Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United KingdomLizzie Flude1Physiotherapy, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
- Reduced expression of interferon stimulated genes in refractory asthmaBy Jane da Silva, Monique Henket, Michael Edwards, Sebastian Johnston and Renaud LouisJane da Silva1Department of Medicine and Post-Graduate Program in Health Science, University of South of Santa Catarina - UNISUL, Tubarao, SC, BrazilMonique Henket2Department of Pneumology, GIGA I 3 Research group, CHU, University of Liege, Liege, BelgiumMichael Edwards3Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College, London, United KingdomSebastian Johnston3Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College, London, United KingdomRenaud Louis2Department of Pneumology, GIGA I 3 Research group, CHU, University of Liege, Liege, Belgium
- Genetic predisposition to RSV infection and associated respiratory morbidity in preterm infantsBy Simon Drysdale, Michael Prendergast, Mireia Alcazar-Paris, Theresa Wilson, Melvyn Smith, Mark Zuckerman, Simon Broughton, Gerrard Rafferty, Sebastian Johnston, Hennie Hodemaekers, Riny Janssen, Louis Bont and Anne GreenoughSimon Drysdale1Division of Asthma, Allergy and Lung Biology, King's College London, London, United KingdomMichael Prendergast1Division of Asthma, Allergy and Lung Biology, King's College London, London, United KingdomMireia Alcazar-Paris1Division of Asthma, Allergy and Lung Biology, King's College London, London, United KingdomTheresa Wilson1Division of Asthma, Allergy and Lung Biology, King's College London, London, United KingdomMelvyn Smith2South London Specialist Virology Centre, King's College Hospital, London, United KingdomMark Zuckerman2South London Specialist Virology Centre, King's College Hospital, London, United KingdomSimon Broughton1Division of Asthma, Allergy and Lung Biology, King's College London, London, United KingdomGerrard Rafferty1Division of Asthma, Allergy and Lung Biology, King's College London, London, United KingdomSebastian Johnston3Airways Disease Infection Section, National Heart and Lung Instititute, Imperial College, London, United KingdomHennie Hodemaekers4Laboratory for Toxicology, Pathology and Genetics, National Institute for Public Health and the Environment, Bilthoven, NetherlandsRiny Janssen4Laboratory for Toxicology, Pathology and Genetics, National Institute for Public Health and the Environment, Bilthoven, NetherlandsLouis Bont5Wilhelmina Children's Hospital, University Medical Centre, Utrecht, NetherlandsAnne Greenough1Division of Asthma, Allergy and Lung Biology, King's College London, London, United Kingdom
- Adaptation of prevotella during acute infectious pulmonary exacerbationBy Stuart Elborn, Denver Mooney, Michael Tunney, Stephanie McGrath, Leanne McIlreavey, Elinor Johnston and Thomas MatierStuart Elborn1CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomDenver Mooney1CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomMichael Tunney1CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomStephanie McGrath1CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomLeanne McIlreavey1CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomElinor Johnston1CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomThomas Matier1CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United Kingdom
- Anti-inflammatory effects of the novel PDE4 inhibitor CHF6001 on virus inducible cytokinesBy Michael Edwards, Fabrizio Facchinetti, Maurizio Civelli, Gino Villetti and Sebastian JohnstonMichael Edwards1Airway Disease Infection Section, MRC Centre for Allergic Mechanisms of Asthma, Imperial College London, London, United KingdomFabrizio Facchinetti2Corporate Pre-Clinical R&D, Chiesi Farmaceutici, Parma, ItalyMaurizio Civelli2Corporate Pre-Clinical R&D, Chiesi Farmaceutici, Parma, ItalyGino Villetti2Corporate Pre-Clinical R&D, Chiesi Farmaceutici, Parma, ItalySebastian Johnston1Airway Disease Infection Section, MRC Centre for Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom
- Plasma pro-surfactant protein B and lung function decline in smokersBy Janice M. Leung, John Mayo, Wan Tan, C. Martin Tammemagi, Geoffrey Liu, Stuart Peacock, Frances A. Shepherd, John Goffin, Glenwood Goss, Garth Nicholas, Alain Tremblay, Michael Johnston, Simon Martel, Francis Laberge, Rick Bhatia, Heidi Roberts, Paul Burrowes, Daria Manos, Lori Stewart, Michel Gingras, Sergio Pasian, Ming-Sound Tsao, Stephen Lam and Don D. SinArticle | Published in 2015 in European Respiratory JournalJanice M. Leung1Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada2Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, CanadaJohn Mayo3Dept of Radiology, University of British Columbia, Vancouver, BC, CanadaWan Tan1Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada2Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, CanadaC. Martin Tammemagi4Dept of Community Health Sciences, Brock University, St Catharines, ON, CanadaGeoffrey Liu5University Health Network, Ontario Cancer Institute, and Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, CanadaStuart Peacock6The Canadian Centre for Applied Research in Cancer Control, Vancouver, BC, Canada7The British Columbia Cancer Agency, Vancouver, BC, CanadaFrances A. Shepherd5University Health Network, Ontario Cancer Institute, and Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, CanadaJohn Goffin8The Juravinsky Cancer Centre, Hamilton, ON, CanadaGlenwood Goss9The Ottawa Hospital, Ottawa, ON, CanadaGarth Nicholas10Ottawa Hospital Research Institute, Ottawa, ON, CanadaAlain Tremblay11University of Calgary, Foothills Medical Centre, Calgary, AB, CanadaMichael Johnston12Beatrice Hunter Cancer Research Institute and Dalhousie University, Halifax, NS, CanadaSimon Martel13Institut universitaire de cardiologie et de pneumologie de Québec and Laval University, Québec, QC, CanadaFrancis Laberge13Institut universitaire de cardiologie et de pneumologie de Québec and Laval University, Québec, QC, CanadaRick Bhatia14Memorial University, St John's, NL, CanadaHeidi Roberts5University Health Network, Ontario Cancer Institute, and Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, CanadaPaul Burrowes11University of Calgary, Foothills Medical Centre, Calgary, AB, CanadaDaria Manos15Queen Elizabeth II Health Sciences Centre, Halifax, NS, CanadaLori Stewart16Dept of Diagnostic Imaging, Henderson Hospital, Hamilton, ON, CanadaMichel Gingras13Institut universitaire de cardiologie et de pneumologie de Québec and Laval University, Québec, QC, CanadaSergio Pasian13Institut universitaire de cardiologie et de pneumologie de Québec and Laval University, Québec, QC, CanadaMing-Sound Tsao5University Health Network, Ontario Cancer Institute, and Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, CanadaStephen Lam1Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada7The British Columbia Cancer Agency, Vancouver, BC, CanadaDon D. Sin1Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada2Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada
- Inflammatory biomarkers in urine of cystic fibrosis patientsBy Gita Parekh, Michael Tunney, Emilie Vallières, Stef McGrath, Leanne McIlreavey, Elinor Johnston, Damian Downey, Kevin Woolston, Paul Davis and Stuart ElbornGita Parekh1Mologic Ltd., Thurleigh, Bedford, United KingdomMichael Tunney2CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomEmilie Vallières2CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomStef McGrath2CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomLeanne McIlreavey2CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomElinor Johnston2CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United KingdomDamian Downey3Adult CF Centre, Belfast Health and Social Care Trust, Belfast, United KingdomKevin Woolston1Mologic Ltd., Thurleigh, Bedford, United KingdomPaul Davis1Mologic Ltd., Thurleigh, Bedford, United KingdomStuart Elborn2CF & Airways Microbiology Research Group, Queen's University Belfast, Belfast, United Kingdom
- Plasma pro-surfactant protein B and lung function decline in smokersBy Janice M. Leung, John Mayo, Wan Tan, C. Martin Tammemagi, Geoffrey Liu, Stuart Peacock, Frances A. Shepherd, John Goffin, Glenwood Goss, Garth Nicholas, Alain Tremblay, Michael Johnston, Simon Martel, Francis Laberge, Rick Bhatia, Heidi Roberts, Paul Burrowes, Daria Manos, Lori Stewart, Michel Gingras, Sergio Pasian, Ming-Sound Tsao, Stephen Lam and Don D. SinJanice M. Leung1Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada2Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, CanadaJohn Mayo3Dept of Radiology, University of British Columbia, Vancouver, BC, CanadaWan Tan1Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada2Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, CanadaC. Martin Tammemagi4Dept of Community Health Sciences, Brock University, St Catharines, ON, CanadaGeoffrey Liu5University Health Network, Ontario Cancer Institute, and Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, CanadaStuart Peacock6The Canadian Centre for Applied Research in Cancer Control, Vancouver, BC, Canada7The British Columbia Cancer Agency, Vancouver, BC, CanadaFrances A. Shepherd5University Health Network, Ontario Cancer Institute, and Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, CanadaJohn Goffin8The Juravinsky Cancer Centre, Hamilton, ON, CanadaGlenwood Goss9The Ottawa Hospital, Ottawa, ON, CanadaGarth Nicholas10Ottawa Hospital Research Institute, Ottawa, ON, CanadaAlain Tremblay11University of Calgary, Foothills Medical Centre, Calgary, AB, CanadaMichael Johnston12Beatrice Hunter Cancer Research Institute and Dalhousie University, Halifax, NS, CanadaSimon Martel13Institut universitaire de cardiologie et de pneumologie de Québec and Laval University, Québec, QC, CanadaFrancis Laberge13Institut universitaire de cardiologie et de pneumologie de Québec and Laval University, Québec, QC, CanadaRick Bhatia14Memorial University, St John's, NL, CanadaHeidi Roberts5University Health Network, Ontario Cancer Institute, and Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, CanadaPaul Burrowes11University of Calgary, Foothills Medical Centre, Calgary, AB, CanadaDaria Manos15Queen Elizabeth II Health Sciences Centre, Halifax, NS, CanadaLori Stewart16Dept of Diagnostic Imaging, Henderson Hospital, Hamilton, ON, CanadaMichel Gingras13Institut universitaire de cardiologie et de pneumologie de Québec and Laval University, Québec, QC, CanadaSergio Pasian13Institut universitaire de cardiologie et de pneumologie de Québec and Laval University, Québec, QC, CanadaMing-Sound Tsao5University Health Network, Ontario Cancer Institute, and Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, CanadaStephen Lam1Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada7The British Columbia Cancer Agency, Vancouver, BC, CanadaDon D. Sin1Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada2Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada
- LSC Abstract – Bacterial burden in rhinovirus-induced asthma exacerbationsBy Ernie Wong, Michael Edwards, William Cookson, David Jackson and Sebastian JohnstonErnie Wong1Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom2Genomic Medicine Section, National Heart and Lung Institute, London, United Kingdom3MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom4Respiratory Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom5Centre for Respiratory Infection, London, United KingdomMichael Edwards1Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom3MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom5Centre for Respiratory Infection, London, United KingdomWilliam Cookson2Genomic Medicine Section, National Heart and Lung Institute, London, United Kingdom3MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, United KingdomDavid Jackson1Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom3MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom4Respiratory Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom5Centre for Respiratory Infection, London, United KingdomSebastian Johnston1Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom3MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom4Respiratory Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom5Centre for Respiratory Infection, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.